News Highlights: Top Equities Stories Of The Day
May 06 2016 - 3:06AM
Dow Jones News
ArcelorMittal Narrows Losses, Cautions on China
Steel giant ArcelorMittal narrowed its net loss in the first
quarter and forecast improved earnings to come as steel prices
begin to recover, but cautioned that excess steel capacity in China
still remains a concern.
Goldman Sachs Cuts More Jobs in its Securities Business
Goldman Sachs is trimming additional staff from its sales and
trading division, people familiar with the matter said, marking
another wave of cost cuts for the Wall Street firm.
China's HNA in Talks to Buy Singapore Logistics Firm
The Chinese conglomerate is in advanced discussions to buy a
controlling stake in CWT-something that would trigger an offer for
the entire company valued at about US$1 billion.
Venezuela Official Sues Dow Jones, News Corp. for Libel
A top government official in Venezuela has sued Dow Jones &
Co. Inc. and News Corp. for libel, accusing reporters from The Wall
Street Journal of making false allegations about him related to
drug trafficking and money laundering.
News Corp Reports Loss on Legal Settlement
News Corp swung to a loss in the March quarter, hurt by a legal
settlement, turmoil in the advertising markets and foreign-currency
fluctuations.
Valeant Forms Committee to Determine Drug Prices
Valeant Pharmaceuticals International Inc., which has come under
heavy fire from politicians because of dramatic price increases for
its drugs, said it had formed a committee that will be responsible
for those prices going forward.
Herbalife Nears Resolution of FTC Probe
Herbalife Ltd. said it was nearing a resolution to a regulatory
investigation into whether the company was operating as a pyramid
scheme.
LinkedIn Buys Run Hop, Seeks to Make Feeds More Engaging
The professional social network said the acquisition targeted
talent instead of technology as LinkedIn invests in content.
Endo Cuts Annual Guidance on Impairment Charge
Endo International PLC on Thursday reported its losses deepened
in its latest quarter, pressured by an asset impairment charge,
leading the pharmaceutical company to cut annual guidance.
(END) Dow Jones Newswires
May 06, 2016 02:51 ET (06:51 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.